By contrast, although the effect values for the CRC patients showed significant interstudy heterogeneity, the pooled results of the random effects model suggested a close relationship (P < 0.001) between RASSF1A methylation and CRC prognosis (Figure 3(b)). This evidence concerns the gene RASSF1 and colorectal carcinoma.